State of Wisconsin Investment Board’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-16,400
Closed -$74K 2013
2020
Q2
$74K Buy
+16,400
New +$73.3K ﹤0.01% 1685
2020
Q1
Sell
-55,500
Closed -$471K 1757
2019
Q4
$471K Hold
55,500
﹤0.01% 1465
2019
Q3
$380K Buy
55,500
+12,600
+29% +$92.4K ﹤0.01% 1407
2019
Q2
$357K Buy
42,900
+900
+2% +$7.76K ﹤0.01% 1406
2019
Q1
$385K Buy
42,000
+9,700
+30% +$98.5K ﹤0.01% 1399
2018
Q4
$354K Buy
32,300
+300
+0.9% +$3.78K ﹤0.01% 1391
2018
Q3
$446K Buy
32,000
+17,000
+113% +$230K ﹤0.01% 1423
2018
Q2
$160K Hold
15,000
﹤0.01% 1439
2018
Q1
$130K Hold
15,000
﹤0.01% 1419
2017
Q4
$142K Hold
15,000
﹤0.01% 1410
2017
Q3
$118K Hold
15,000
﹤0.01% 1433
2017
Q2
$129K Buy
+15,000
New +$108K ﹤0.01% 1431

Other funds holding KIN

State of Wisconsin Investment Board's KIN Position: Q3 2020 in Review

State of Wisconsin Investment Board sold out of Kindred Biosciences, Inc. (KIN) in Q3 2020, closing a stake of 16,400 shares — an estimated $74K sold.

State of Wisconsin Investment Board first reported a position in KIN in Q2 2017 and held it in 12 quarters. The position peaked at $471K in Q4 2019. 77 funds tracked by Wall St. Rank hold KIN as of Q3 2020.

  • State of Wisconsin Investment Board reported no remaining Kindred Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 16,400 Kindred Biosciences, Inc. shares in Q3 2020, an estimated $74K.
  • State of Wisconsin Investment Board first reported a position in Kindred Biosciences, Inc. in Q2 2017 and held it in 12 quarters.
  • State of Wisconsin Investment Board's Kindred Biosciences, Inc. position peaked at $471K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2020, filed 16 Nov 2020.